PEGCETACOPLAN (APL-2)
APL2-103
Phase 1 small_molecule completed
Quick answer
PEGCETACOPLAN (APL-2) for Geographic Atrophy is a Phase 1 program (small_molecule) at Apellis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Apellis Pharmaceuticals
- Indication
- Geographic Atrophy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed